Evidence map›Paper›PMID 41902807›Full record

ArticleMayo Clinic proceedings2026

Perspective: Taxonomy of Kidney Diseases and Disorders Related to Nephrotoxic Drug Exposure in Hospitalized Patients.

Sandra L Kane-Gill, Erin F Barreto, Alexander H Flannery, Todd A Miano, Raghavan Murugan, Tezcan Ozrazgat-Baslanti, Azra Bihorac, John A Kellum, MEnD-AKI Study and Acute Kidney Intervention and Pharmacotherapy Group

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Mayo Clinic proceedings, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sandra L Kane-GillDepartment of Pharmacy and Therapeutics, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA; Department of Pharmacy, UPMC, Pittsburgh, PA; Department of Critical Care Medicine, Center for Critical Care Nephrology, Pittsburgh, PA. Electronic address: kane-gill@pitt.edu.
Erin F BarretoDepartment of Pharmacy, Mayo Clinic, Rochester, MN.
Alexander H FlanneryDepartment of Pharmacy Practice and Science, College of Pharmacy, University of Kentucky, Lexington, KY.
Todd A MianoDepartment of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
Raghavan MuruganDepartment of Critical Care Medicine, Center for Critical Care Nephrology, Pittsburgh, PA.
Tezcan Ozrazgat-BaslantiIntelligent Clinical Care Center University of Florida, Gainesville, FL; Department of Medicine, University of Florida, Gainesville, FL.
Azra BihoracIntelligent Clinical Care Center University of Florida, Gainesville, FL; Department of Medicine, University of Florida, Gainesville, FL.
John A KellumDepartment of Critical Care Medicine, Center for Critical Care Nephrology, Pittsburgh, PA.
MEnD-AKI Study and Acute Kidney Intervention and Pharmacotherapy Group

Funding

(MEnD-AKI) Multicenter Implementation of an Electronic Decision Support System for Drug-associated AKIR01DK121730 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BIHORAC, AZRA, KANE-GILL, SANDRA L · 2021 to 2025
$3.2M
Beta-lactam individualization for critically ill patientsK23AI143882 · NIAID · MAYO CLINIC ROCHESTER · PI BARRETO, ERIN FRAZEE · 2020 to 2024
$986k
NIAID NIH HHS K23 AI143882NIDDK NIH HHS R01 DK121730
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41902807
PMCPMC13091705

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.